Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration

Abstract It is of urgent need to identify the exact physico-chemical characteristics which allow maximum uptake and accumulation in secondary target organs of nanoparticulate drug delivery systems after oral ingestion. We administered radiolabelled gold nanoparticles in different sizes (1.4–200 nm) with negative surface charge and 2.8 nm nanoparticles with opposite surface charges by intra-oesophageal instillation into healthy adult female rats. The quantitative amount of the particles in organs, tissues and excrements was measured after 24 h by gamma-spectroscopy. The highest accumulation in secondary organs was mostly found for 1.4 nm particles; the negatively charged particles were accumulated mostly more than positively charged particles. Importantly, 18 nm particles show a higher accumulation in brain and heart compared to other sized particles. No general rule accumulation can be made so far. Therefore, specialized drug delivery systems via the oral route have to be individually designed, depending on the respective target organ.

[1]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[2]  Hiroyuki Ohshima,et al.  In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[3]  G W Halbert,et al.  The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats , 1989, The Journal of pharmacy and pharmacology.

[4]  Jonathan S Dordick,et al.  Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[5]  G Pohlmann,et al.  A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  Chun-Ting Kuo,et al.  On the size evolution of gold-monolayer-protected clusters by ligand place-exchange reactions: the effect of headgroup-gold interactions. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[7]  Wolfgang Kreyling,et al.  Ultrafine Particles Cross Cellular Membranes by Nonphagocytic Mechanisms in Lungs and in Cultured Cells , 2005, Environmental health perspectives.

[8]  A. Gebert,et al.  M cells in Peyer's patches of the intestine. , 1996, International review of cytology.

[9]  Cui Tang,et al.  Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.

[10]  M. Hashida,et al.  Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats. , 1996, Journal of drug targeting.

[11]  W. Saltzman,et al.  The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. , 2009, Biomaterials.

[12]  Sabine Neuss,et al.  Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. , 2009, Small.

[13]  Manuela Semmler-Behnke,et al.  Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.

[14]  Alexander T. Florence,et al.  Utilizing Bacterial Mechanisms of Epithelial Cell Entry: Invasin-induced Oral Uptake of Latex Nanoparticles , 2004, Pharmaceutical Research.

[15]  G. Schmid,et al.  Tracer Diffusion of a Ligand-Stabilized Two-Shell Gold Cluster , 1996 .

[16]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[17]  U. Bakowsky,et al.  Design of Estradiol Loaded PLGA Nanoparticulate Formulations: A Potential Oral Delivery System for Hormone Therapy , 2006, Pharmaceutical Research.

[18]  J. Dordick,et al.  Cytochrome C on silica nanoparticles: influence of nanoparticle size on protein structure, stability, and activity. , 2009, Small.

[19]  Parag Aggarwal,et al.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[20]  J. Seifert,et al.  Intestinal absorption of macromolecules and small particles. , 1990, Digestive diseases.

[21]  Parag Aggarwal,et al.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.

[22]  A T Florence,et al.  Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. , 1994, Journal of drug targeting.

[23]  R. Murray,et al.  Reaction of Au(55)(PPh(3))(12)Cl(6) with thiols yields thiolate monolayer protected Au(75) clusters. , 2005, Journal of the American Chemical Society.

[24]  Ravi S Kane,et al.  Increasing protein stability through control of the nanoscale environment. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[25]  R M Albrecht,et al.  Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. , 2001, Journal of pharmaceutical sciences.

[26]  R. Murray,et al.  Reaction of Au55(PPh3)12Cl6 with thiols yields thiolate monolayer protected Au75 clusters , 2005 .

[27]  A. Florence,et al.  Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency , 1990, The Journal of pharmacy and pharmacology.

[28]  Sabine Neuss,et al.  Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.

[29]  P. Artursson,et al.  Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[30]  Bengt-Harald Jonsson,et al.  Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[31]  M. Rescigno,et al.  Uptake and presentation of orally administered antigens. , 2005, Vaccine.

[32]  K. Carr,et al.  Factors influencing intestinal microparticle uptake in vivo. , 2007, International journal of pharmaceutics.

[33]  M. Loeffler,et al.  Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. , 1990, Development.

[34]  Monic Shah,et al.  Biological applications of gold nanoparticles. , 2014, Journal of nanoscience and nanotechnology.

[35]  Jack F Douglas,et al.  Interaction of gold nanoparticles with common human blood proteins. , 2010, ACS nano.

[36]  C. Lehr,et al.  PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat , 2009, Pharmaceutical Research.

[37]  J. Powell,et al.  Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. , 2010, Journal of autoimmunity.

[38]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[39]  Pakatip Ruenraroengsak,et al.  Nanosystem drug targeting: Facing up to complex realities. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[40]  R. Samstein,et al.  The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. , 2008, Biomaterials.

[41]  Yves-Jacques Schneider,et al.  Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[42]  J. Seifert,et al.  Rapid insorption of small particles in the gut. , 1990, The American journal of gastroenterology.

[43]  N. Krug,et al.  Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models , 2009, Inhalation toxicology.

[44]  A. Konig,et al.  [Blood volume of rat organs and residual amount of blood after blood letting or irrigation; determination with radiophosphorus-labeled erythrocytes]. , 1955, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie.

[45]  Manuela Semmler-Behnke,et al.  Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  N Hussain,et al.  Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. , 1995, Journal of drug targeting.

[47]  U. Schumacher,et al.  Uptake of inert microparticles in normal and immune deficient mice. , 2008, International journal of pharmaceutics.

[48]  M. Morishita,et al.  Effects of isoflurane on gastrointestinal motility after brief exposure in rats. , 2005, International journal of pharmaceutics.

[49]  T. Fuchigami,et al.  Electrochemical asymmetric reduction of prochiral carbonyl compounds, oximes, and a gem-dihalide on a poly-L-valine-coated graphite electrode. , 1983 .

[50]  A. König,et al.  Das Blutvolumen einiger Rattenorgane und ihre Restblutmenge nach Entbluten bzw. Durchspülung. Bestimmung mit P32-markierten Erythrocyten , 2004, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.

[51]  Alexander T Florence,et al.  Pharmaceutical nanotechnology: more than size. Ten topics for research. , 2007, International journal of pharmaceutics.

[52]  A T Florence,et al.  Oral uptake and translocation of a polylysine dendrimer with a lipid surface. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[53]  J. Seifert,et al.  The influence of age and particle number on absorption of polystyrene particles from the rat gut. , 1996, Journal of anatomy.

[54]  Mina Choi,et al.  The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. , 2009, Toxicology letters.

[55]  G. Schmid The relevance of shape and size of Au55 clusters. , 2008, Chemical Society reviews.